Trials / Completed
CompletedNCT01979926
Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis
Double-blind, A Multicenter, Randomized, Placebo-controlled, Parallel, Phase 2 Study to Comparative Evaluate the Efficacy of N02RS1 600mg/Day, 12,00mg/Day in Korean Patients With Acute and Chronic Bronchitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- PharmaKing · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The Purpose of A Multicenter, Randomized, Double-blind, Placebo-controlled to Evaluate the Efficacy, Safety and Pharmacokinetics of N02RS1 600mg and 1,200mg per day in Patients With acute and acute exacerbation of chronic bronchitis for 7 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Combination of Broussonetia spp and Lonicera spp | 600 mg/ day or 1200 mg/ day for 7 days |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2013-11-01
- Completion
- 2014-03-01
- First posted
- 2013-11-08
- Last updated
- 2014-05-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01979926. Inclusion in this directory is not an endorsement.